nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A1—breast cancer	0.121	0.461	CbGaD
Albendazole—TUBB4B—Eribulin—breast cancer	0.093	0.172	CbGbCtD
Albendazole—TUBB4B—Ixabepilone—breast cancer	0.0892	0.165	CbGbCtD
Albendazole—CYP3A4—breast cancer	0.0771	0.294	CbGaD
Albendazole—TUBA1A—Vinblastine—breast cancer	0.0769	0.142	CbGbCtD
Albendazole—ABCB1—breast cancer	0.0642	0.245	CbGaD
Albendazole—TUBB4B—Vinorelbine—breast cancer	0.0476	0.088	CbGbCtD
Albendazole—TUBB4B—Paclitaxel—breast cancer	0.0335	0.0618	CbGbCtD
Albendazole—TUBB4B—Vinblastine—breast cancer	0.0294	0.0542	CbGbCtD
Albendazole—TUBB4B—Docetaxel—breast cancer	0.0242	0.0447	CbGbCtD
Albendazole—CYP1A1—Toremifene—breast cancer	0.0214	0.0396	CbGbCtD
Albendazole—CYP1A2—Anastrozole—breast cancer	0.0105	0.0193	CbGbCtD
Albendazole—CYP1A2—Toremifene—breast cancer	0.00958	0.0177	CbGbCtD
Albendazole—ABCB1—Toremifene—breast cancer	0.00838	0.0155	CbGbCtD
Albendazole—CYP1A1—Tamoxifen—breast cancer	0.00783	0.0145	CbGbCtD
Albendazole—CYP3A4—Exemestane—breast cancer	0.00724	0.0134	CbGbCtD
Albendazole—CYP3A4—Letrozole—breast cancer	0.00616	0.0114	CbGbCtD
Albendazole—ABCB1—Lapatinib—breast cancer	0.00611	0.0113	CbGbCtD
Albendazole—CYP3A4—Anastrozole—breast cancer	0.00549	0.0101	CbGbCtD
Albendazole—CYP3A4—Toremifene—breast cancer	0.00502	0.00927	CbGbCtD
Albendazole—CYP3A4—Fulvestrant—breast cancer	0.00467	0.00862	CbGbCtD
Albendazole—CYP3A4—Thiotepa—breast cancer	0.00416	0.00768	CbGbCtD
Albendazole—CYP3A4—Ixabepilone—breast cancer	0.0038	0.00703	CbGbCtD
Albendazole—CYP3A4—Lapatinib—breast cancer	0.00366	0.00676	CbGbCtD
Albendazole—CYP1A2—Tamoxifen—breast cancer	0.0035	0.00646	CbGbCtD
Albendazole—ABCB1—Vinorelbine—breast cancer	0.00339	0.00626	CbGbCtD
Albendazole—ABCB1—Tamoxifen—breast cancer	0.00306	0.00565	CbGbCtD
Albendazole—ABCB1—Mitoxantrone—breast cancer	0.00298	0.00551	CbGbCtD
Albendazole—CYP3A4—Raloxifene—breast cancer	0.00278	0.00513	CbGbCtD
Albendazole—ABCB1—Gemcitabine—breast cancer	0.00264	0.00487	CbGbCtD
Albendazole—CYP1A2—Fluorouracil—breast cancer	0.00258	0.00476	CbGbCtD
Albendazole—ABCB1—Paclitaxel—breast cancer	0.00238	0.0044	CbGbCtD
Albendazole—ABCB1—Irinotecan—breast cancer	0.00235	0.00434	CbGbCtD
Albendazole—ABCB1—Vinblastine—breast cancer	0.00209	0.00386	CbGbCtD
Albendazole—CYP3A4—Vinorelbine—breast cancer	0.00203	0.00375	CbGbCtD
Albendazole—TUBA1A—mammary gland—breast cancer	0.00185	0.0641	CbGeAlD
Albendazole—CYP3A4—Tamoxifen—breast cancer	0.00183	0.00339	CbGbCtD
Albendazole—CYP3A4—Mitoxantrone—breast cancer	0.00179	0.0033	CbGbCtD
Albendazole—ABCB1—Docetaxel—breast cancer	0.00172	0.00318	CbGbCtD
Albendazole—TUBA1A—Zalcitabine—Gemcitabine—breast cancer	0.00161	0.826	CbGdCrCtD
Albendazole—TUBA1A—nipple—breast cancer	0.00153	0.053	CbGeAlD
Albendazole—CYP3A4—Paclitaxel—breast cancer	0.00143	0.00264	CbGbCtD
Albendazole—CYP3A4—Irinotecan—breast cancer	0.00141	0.0026	CbGbCtD
Albendazole—ABCB1—Doxorubicin—breast cancer	0.00128	0.00237	CbGbCtD
Albendazole—TUBA1A—embryo—breast cancer	0.00127	0.0437	CbGeAlD
Albendazole—CYP3A4—Vinblastine—breast cancer	0.00125	0.00231	CbGbCtD
Albendazole—ABCB1—Methotrexate—breast cancer	0.00124	0.0023	CbGbCtD
Albendazole—TUBB4B—mammary gland—breast cancer	0.00124	0.0427	CbGeAlD
Albendazole—TUBA1A—epithelium—breast cancer	0.00103	0.0357	CbGeAlD
Albendazole—CYP3A4—Docetaxel—breast cancer	0.00103	0.00191	CbGbCtD
Albendazole—TUBB4B—nipple—breast cancer	0.00102	0.0353	CbGeAlD
Albendazole—TUBA1A—skin of body—breast cancer	0.000982	0.034	CbGeAlD
Albendazole—TUBA1A—endometrium—breast cancer	0.000926	0.032	CbGeAlD
Albendazole—TUBA1A—uterus—breast cancer	0.000854	0.0295	CbGeAlD
Albendazole—TUBB4B—embryo—breast cancer	0.000844	0.0292	CbGeAlD
Albendazole—TUBA1A—pituitary gland—breast cancer	0.000838	0.029	CbGeAlD
Albendazole—TUBA1A—adipose tissue—breast cancer	0.000835	0.0289	CbGeAlD
Albendazole—CYP3A4—Doxorubicin—breast cancer	0.000769	0.00142	CbGbCtD
Albendazole—TUBA1A—female reproductive system—breast cancer	0.000767	0.0265	CbGeAlD
Albendazole—TUBA1A—adrenal gland—breast cancer	0.000749	0.0259	CbGeAlD
Albendazole—TUBA1A—bone marrow—breast cancer	0.000724	0.025	CbGeAlD
Albendazole—TUBA1A—female gonad—breast cancer	0.000698	0.0241	CbGeAlD
Albendazole—TUBB4B—skin of body—breast cancer	0.000655	0.0226	CbGeAlD
Albendazole—TUBA1A—endocrine gland—breast cancer	0.000649	0.0224	CbGeAlD
Albendazole—TUBB4B—endometrium—breast cancer	0.000617	0.0213	CbGeAlD
Albendazole—CYP1A2—nipple—breast cancer	0.00058	0.0201	CbGeAlD
Albendazole—CYP1A1—nipple—breast cancer	0.000573	0.0198	CbGeAlD
Albendazole—TUBB4B—uterus—breast cancer	0.000569	0.0197	CbGeAlD
Albendazole—TUBB4B—pituitary gland—breast cancer	0.000559	0.0193	CbGeAlD
Albendazole—TUBB4B—adipose tissue—breast cancer	0.000556	0.0192	CbGeAlD
Albendazole—Mebendazole—CYP1A1—breast cancer	0.00055	0.461	CrCbGaD
Albendazole—TUBB4B—female reproductive system—breast cancer	0.000511	0.0177	CbGeAlD
Albendazole—TUBB4B—adrenal gland—breast cancer	0.000499	0.0172	CbGeAlD
Albendazole—TUBB4B—bone marrow—breast cancer	0.000483	0.0167	CbGeAlD
Albendazole—TUBB4B—female gonad—breast cancer	0.000465	0.0161	CbGeAlD
Albendazole—TUBA1A—lymph node—breast cancer	0.000449	0.0155	CbGeAlD
Albendazole—TUBB4B—endocrine gland—breast cancer	0.000433	0.015	CbGeAlD
Albendazole—CYP1A1—epithelium—breast cancer	0.000385	0.0133	CbGeAlD
Albendazole—CYP1A1—skin of body—breast cancer	0.000367	0.0127	CbGeAlD
Albendazole—Mebendazole—CYP3A4—breast cancer	0.000351	0.294	CrCbGaD
Albendazole—TUBA1A—Azacitidine—Gemcitabine—breast cancer	0.000339	0.174	CbGdCrCtD
Albendazole—CYP1A1—uterus—breast cancer	0.000319	0.011	CbGeAlD
Albendazole—CYP1A1—adipose tissue—breast cancer	0.000312	0.0108	CbGeAlD
Albendazole—TUBB4B—lymph node—breast cancer	0.000299	0.0103	CbGeAlD
Albendazole—Mebendazole—ABCB1—breast cancer	0.000292	0.245	CrCbGaD
Albendazole—CYP1A1—female reproductive system—breast cancer	0.000286	0.0099	CbGeAlD
Albendazole—CYP1A1—female gonad—breast cancer	0.000261	0.00901	CbGeAlD
Albendazole—CYP1A2—endocrine gland—breast cancer	0.000246	0.00849	CbGeAlD
Albendazole—ABCB1—embryo—breast cancer	0.000245	0.00848	CbGeAlD
Albendazole—CYP1A1—endocrine gland—breast cancer	0.000242	0.00838	CbGeAlD
Albendazole—CYP3A4—female reproductive system—breast cancer	0.00021	0.00726	CbGeAlD
Albendazole—ABCB1—epithelium—breast cancer	0.0002	0.00692	CbGeAlD
Albendazole—ABCB1—endometrium—breast cancer	0.00018	0.00621	CbGeAlD
Albendazole—CYP3A4—endocrine gland—breast cancer	0.000178	0.00615	CbGeAlD
Albendazole—CYP1A1—lymph node—breast cancer	0.000168	0.00579	CbGeAlD
Albendazole—ABCB1—uterus—breast cancer	0.000165	0.00572	CbGeAlD
Albendazole—ABCB1—pituitary gland—breast cancer	0.000162	0.00562	CbGeAlD
Albendazole—ABCB1—adipose tissue—breast cancer	0.000162	0.00559	CbGeAlD
Albendazole—ABCB1—female reproductive system—breast cancer	0.000149	0.00514	CbGeAlD
Albendazole—ABCB1—adrenal gland—breast cancer	0.000145	0.00502	CbGeAlD
Albendazole—ABCB1—bone marrow—breast cancer	0.00014	0.00485	CbGeAlD
Albendazole—ABCB1—female gonad—breast cancer	0.000135	0.00468	CbGeAlD
Albendazole—ABCB1—endocrine gland—breast cancer	0.000126	0.00435	CbGeAlD
Albendazole—Leukopenia—Mitoxantrone—breast cancer	0.000123	0.00133	CcSEcCtD
Albendazole—Leukopenia—Irinotecan—breast cancer	0.000123	0.00133	CcSEcCtD
Albendazole—Erythema multiforme—Paclitaxel—breast cancer	0.000122	0.00131	CcSEcCtD
Albendazole—Urticaria—Goserelin—breast cancer	0.000121	0.0013	CcSEcCtD
Albendazole—Hypersensitivity—Vinblastine—breast cancer	0.000121	0.0013	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Docetaxel—breast cancer	0.000121	0.0013	CcSEcCtD
Albendazole—Abdominal pain—Goserelin—breast cancer	0.00012	0.00129	CcSEcCtD
Albendazole—Body temperature increased—Goserelin—breast cancer	0.00012	0.00129	CcSEcCtD
Albendazole—Leukopenia—Gemcitabine—breast cancer	0.00012	0.00129	CcSEcCtD
Albendazole—Leukopenia—Fluorouracil—breast cancer	0.000118	0.00127	CcSEcCtD
Albendazole—Hypersensitivity—Tamoxifen—breast cancer	0.000117	0.00126	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Capecitabine—breast cancer	0.000117	0.00126	CcSEcCtD
Albendazole—Immune system disorder—Paclitaxel—breast cancer	0.000116	0.00125	CcSEcCtD
Albendazole—Renal failure acute—Epirubicin—breast cancer	0.000115	0.00124	CcSEcCtD
Albendazole—Hepatobiliary disease—Docetaxel—breast cancer	0.000115	0.00124	CcSEcCtD
Albendazole—Hypersensitivity—Melphalan—breast cancer	0.000115	0.00124	CcSEcCtD
Albendazole—Alopecia—Paclitaxel—breast cancer	0.000114	0.00123	CcSEcCtD
Albendazole—Vomiting—Chlorambucil—breast cancer	0.000114	0.00122	CcSEcCtD
Albendazole—Agranulocytosis—Docetaxel—breast cancer	0.000114	0.00122	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000113	0.00122	CcSEcCtD
Albendazole—Hypersensitivity—Goserelin—breast cancer	0.000112	0.00121	CcSEcCtD
Albendazole—Hepatobiliary disease—Capecitabine—breast cancer	0.000111	0.0012	CcSEcCtD
Albendazole—Gastrointestinal pain—Vinorelbine—breast cancer	0.000111	0.0012	CcSEcCtD
Albendazole—Agranulocytosis—Capecitabine—breast cancer	0.00011	0.00118	CcSEcCtD
Albendazole—Thrombocytopenia—Irinotecan—breast cancer	0.00011	0.00118	CcSEcCtD
Albendazole—Thrombocytopenia—Mitoxantrone—breast cancer	0.00011	0.00118	CcSEcCtD
Albendazole—Hepatitis—Docetaxel—breast cancer	0.000109	0.00118	CcSEcCtD
Albendazole—Skin disorder—Mitoxantrone—breast cancer	0.000109	0.00117	CcSEcCtD
Albendazole—Dizziness—Vinblastine—breast cancer	0.000108	0.00117	CcSEcCtD
Albendazole—Urticaria—Vinorelbine—breast cancer	0.000108	0.00116	CcSEcCtD
Albendazole—Urinary tract disorder—Docetaxel—breast cancer	0.000108	0.00116	CcSEcCtD
Albendazole—Abdominal pain—Vinorelbine—breast cancer	0.000108	0.00116	CcSEcCtD
Albendazole—Body temperature increased—Vinorelbine—breast cancer	0.000108	0.00116	CcSEcCtD
Albendazole—Urethral disorder—Docetaxel—breast cancer	0.000107	0.00115	CcSEcCtD
Albendazole—Thrombocytopenia—Gemcitabine—breast cancer	0.000107	0.00115	CcSEcCtD
Albendazole—Renal failure acute—Doxorubicin—breast cancer	0.000107	0.00115	CcSEcCtD
Albendazole—Gastrointestinal pain—Thiotepa—breast cancer	0.000106	0.00114	CcSEcCtD
Albendazole—Skin disorder—Gemcitabine—breast cancer	0.000106	0.00114	CcSEcCtD
Albendazole—Nausea—Chlorambucil—breast cancer	0.000106	0.00114	CcSEcCtD
Albendazole—Hepatitis—Capecitabine—breast cancer	0.000106	0.00114	CcSEcCtD
Albendazole—Thrombocytopenia—Fluorouracil—breast cancer	0.000105	0.00113	CcSEcCtD
Albendazole—Dizziness—Tamoxifen—breast cancer	0.000105	0.00113	CcSEcCtD
Albendazole—Liver function test abnormal—Methotrexate—breast cancer	0.000105	0.00113	CcSEcCtD
Albendazole—Urinary tract disorder—Capecitabine—breast cancer	0.000104	0.00112	CcSEcCtD
Albendazole—Vomiting—Vinblastine—breast cancer	0.000104	0.00112	CcSEcCtD
Albendazole—Urethral disorder—Capecitabine—breast cancer	0.000104	0.00112	CcSEcCtD
Albendazole—Erythema multiforme—Docetaxel—breast cancer	0.000103	0.00111	CcSEcCtD
Albendazole—Urticaria—Thiotepa—breast cancer	0.000103	0.00111	CcSEcCtD
Albendazole—Abdominal pain—Thiotepa—breast cancer	0.000103	0.00111	CcSEcCtD
Albendazole—Body temperature increased—Thiotepa—breast cancer	0.000103	0.00111	CcSEcCtD
Albendazole—Headache—Vinblastine—breast cancer	0.000103	0.0011	CcSEcCtD
Albendazole—Vomiting—Tamoxifen—breast cancer	0.000101	0.00109	CcSEcCtD
Albendazole—Vertigo—Paclitaxel—breast cancer	0.000101	0.00108	CcSEcCtD
Albendazole—Dizziness—Goserelin—breast cancer	0.000101	0.00108	CcSEcCtD
Albendazole—Leukopenia—Paclitaxel—breast cancer	0.0001	0.00108	CcSEcCtD
Albendazole—Rash—Tamoxifen—breast cancer	0.0001	0.00108	CcSEcCtD
Albendazole—Hypersensitivity—Vinorelbine—breast cancer	0.0001	0.00108	CcSEcCtD
Albendazole—Dermatitis—Tamoxifen—breast cancer	0.0001	0.00108	CcSEcCtD
Albendazole—Erythema multiforme—Capecitabine—breast cancer	0.0001	0.00108	CcSEcCtD
Albendazole—Headache—Tamoxifen—breast cancer	9.97e-05	0.00107	CcSEcCtD
Albendazole—Vomiting—Melphalan—breast cancer	9.91e-05	0.00107	CcSEcCtD
Albendazole—Immune system disorder—Docetaxel—breast cancer	9.87e-05	0.00106	CcSEcCtD
Albendazole—Liver function test abnormal—Epirubicin—breast cancer	9.84e-05	0.00106	CcSEcCtD
Albendazole—Rash—Melphalan—breast cancer	9.83e-05	0.00106	CcSEcCtD
Albendazole—Dermatitis—Melphalan—breast cancer	9.82e-05	0.00106	CcSEcCtD
Albendazole—Nausea—Vinblastine—breast cancer	9.73e-05	0.00105	CcSEcCtD
Albendazole—Vomiting—Goserelin—breast cancer	9.67e-05	0.00104	CcSEcCtD
Albendazole—Alopecia—Docetaxel—breast cancer	9.66e-05	0.00104	CcSEcCtD
Albendazole—Rash—Goserelin—breast cancer	9.59e-05	0.00103	CcSEcCtD
Albendazole—Hypersensitivity—Thiotepa—breast cancer	9.58e-05	0.00103	CcSEcCtD
Albendazole—Dermatitis—Goserelin—breast cancer	9.58e-05	0.00103	CcSEcCtD
Albendazole—Immune system disorder—Capecitabine—breast cancer	9.56e-05	0.00103	CcSEcCtD
Albendazole—Headache—Goserelin—breast cancer	9.53e-05	0.00102	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	9.49e-05	0.00102	CcSEcCtD
Albendazole—Nausea—Tamoxifen—breast cancer	9.46e-05	0.00102	CcSEcCtD
Albendazole—Alopecia—Capecitabine—breast cancer	9.35e-05	0.00101	CcSEcCtD
Albendazole—Pancytopenia—Methotrexate—breast cancer	9.34e-05	0.00101	CcSEcCtD
Albendazole—Nausea—Melphalan—breast cancer	9.26e-05	0.000996	CcSEcCtD
Albendazole—Neutropenia—Methotrexate—breast cancer	9.2e-05	0.00099	CcSEcCtD
Albendazole—Gastrointestinal pain—Mitoxantrone—breast cancer	9.18e-05	0.000988	CcSEcCtD
Albendazole—Gastrointestinal pain—Irinotecan—breast cancer	9.18e-05	0.000988	CcSEcCtD
Albendazole—Liver function test abnormal—Doxorubicin—breast cancer	9.1e-05	0.000979	CcSEcCtD
Albendazole—Nausea—Goserelin—breast cancer	9.03e-05	0.000972	CcSEcCtD
Albendazole—Dizziness—Vinorelbine—breast cancer	9.01e-05	0.000969	CcSEcCtD
Albendazole—Thrombocytopenia—Paclitaxel—breast cancer	8.97e-05	0.000965	CcSEcCtD
Albendazole—Urticaria—Mitoxantrone—breast cancer	8.92e-05	0.00096	CcSEcCtD
Albendazole—Skin disorder—Paclitaxel—breast cancer	8.9e-05	0.000957	CcSEcCtD
Albendazole—Abdominal pain—Mitoxantrone—breast cancer	8.88e-05	0.000955	CcSEcCtD
Albendazole—Body temperature increased—Mitoxantrone—breast cancer	8.88e-05	0.000955	CcSEcCtD
Albendazole—Body temperature increased—Irinotecan—breast cancer	8.88e-05	0.000955	CcSEcCtD
Albendazole—Abdominal pain—Irinotecan—breast cancer	8.88e-05	0.000955	CcSEcCtD
Albendazole—Pancytopenia—Epirubicin—breast cancer	8.75e-05	0.000941	CcSEcCtD
Albendazole—ABCB1—lymph node—breast cancer	8.7e-05	0.00301	CbGeAlD
Albendazole—Stevens-Johnson syndrome—Methotrexate—breast cancer	8.7e-05	0.000936	CcSEcCtD
Albendazole—Vomiting—Vinorelbine—breast cancer	8.66e-05	0.000932	CcSEcCtD
Albendazole—Body temperature increased—Gemcitabine—breast cancer	8.65e-05	0.000931	CcSEcCtD
Albendazole—Neutropenia—Epirubicin—breast cancer	8.61e-05	0.000926	CcSEcCtD
Albendazole—Dizziness—Thiotepa—breast cancer	8.6e-05	0.000925	CcSEcCtD
Albendazole—Rash—Vinorelbine—breast cancer	8.59e-05	0.000924	CcSEcCtD
Albendazole—Dermatitis—Vinorelbine—breast cancer	8.58e-05	0.000923	CcSEcCtD
Albendazole—Urticaria—Fluorouracil—breast cancer	8.55e-05	0.000919	CcSEcCtD
Albendazole—Headache—Vinorelbine—breast cancer	8.53e-05	0.000918	CcSEcCtD
Albendazole—Leukopenia—Docetaxel—breast cancer	8.51e-05	0.000916	CcSEcCtD
Albendazole—Body temperature increased—Fluorouracil—breast cancer	8.5e-05	0.000915	CcSEcCtD
Albendazole—Hepatobiliary disease—Methotrexate—breast cancer	8.3e-05	0.000893	CcSEcCtD
Albendazole—Vertigo—Capecitabine—breast cancer	8.27e-05	0.00089	CcSEcCtD
Albendazole—Hypersensitivity—Irinotecan—breast cancer	8.27e-05	0.00089	CcSEcCtD
Albendazole—Hypersensitivity—Mitoxantrone—breast cancer	8.27e-05	0.00089	CcSEcCtD
Albendazole—Vomiting—Thiotepa—breast cancer	8.27e-05	0.00089	CcSEcCtD
Albendazole—Leukopenia—Capecitabine—breast cancer	8.24e-05	0.000887	CcSEcCtD
Albendazole—Rash—Thiotepa—breast cancer	8.2e-05	0.000882	CcSEcCtD
Albendazole—Dermatitis—Thiotepa—breast cancer	8.19e-05	0.000881	CcSEcCtD
Albendazole—Agranulocytosis—Methotrexate—breast cancer	8.19e-05	0.000881	CcSEcCtD
Albendazole—Headache—Thiotepa—breast cancer	8.15e-05	0.000877	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Epirubicin—breast cancer	8.14e-05	0.000876	CcSEcCtD
Albendazole—Pancytopenia—Doxorubicin—breast cancer	8.09e-05	0.000871	CcSEcCtD
Albendazole—Nausea—Vinorelbine—breast cancer	8.09e-05	0.00087	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	8.04e-05	0.000865	CcSEcCtD
Albendazole—Neutropenia—Doxorubicin—breast cancer	7.97e-05	0.000857	CcSEcCtD
Albendazole—Hypersensitivity—Fluorouracil—breast cancer	7.92e-05	0.000853	CcSEcCtD
Albendazole—Hepatitis—Methotrexate—breast cancer	7.88e-05	0.000847	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.79e-05	0.000838	CcSEcCtD
Albendazole—Urinary tract disorder—Methotrexate—breast cancer	7.78e-05	0.000837	CcSEcCtD
Albendazole—Hepatobiliary disease—Epirubicin—breast cancer	7.77e-05	0.000835	CcSEcCtD
Albendazole—Nausea—Thiotepa—breast cancer	7.72e-05	0.000831	CcSEcCtD
Albendazole—Urethral disorder—Methotrexate—breast cancer	7.72e-05	0.000831	CcSEcCtD
Albendazole—Agranulocytosis—Epirubicin—breast cancer	7.66e-05	0.000824	CcSEcCtD
Albendazole—Thrombocytopenia—Docetaxel—breast cancer	7.6e-05	0.000818	CcSEcCtD
Albendazole—Skin disorder—Docetaxel—breast cancer	7.54e-05	0.000811	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Doxorubicin—breast cancer	7.53e-05	0.00081	CcSEcCtD
Albendazole—Gastrointestinal pain—Paclitaxel—breast cancer	7.49e-05	0.000806	CcSEcCtD
Albendazole—Erythema multiforme—Methotrexate—breast cancer	7.45e-05	0.000801	CcSEcCtD
Albendazole—Dizziness—Irinotecan—breast cancer	7.43e-05	0.000799	CcSEcCtD
Albendazole—Hepatitis—Epirubicin—breast cancer	7.37e-05	0.000793	CcSEcCtD
Albendazole—Thrombocytopenia—Capecitabine—breast cancer	7.36e-05	0.000792	CcSEcCtD
Albendazole—Skin disorder—Capecitabine—breast cancer	7.3e-05	0.000786	CcSEcCtD
Albendazole—Urinary tract disorder—Epirubicin—breast cancer	7.28e-05	0.000783	CcSEcCtD
Albendazole—Urticaria—Paclitaxel—breast cancer	7.28e-05	0.000783	CcSEcCtD
Albendazole—Abdominal pain—Paclitaxel—breast cancer	7.24e-05	0.000779	CcSEcCtD
Albendazole—Body temperature increased—Paclitaxel—breast cancer	7.24e-05	0.000779	CcSEcCtD
Albendazole—Urethral disorder—Epirubicin—breast cancer	7.23e-05	0.000777	CcSEcCtD
Albendazole—Hepatobiliary disease—Doxorubicin—breast cancer	7.18e-05	0.000773	CcSEcCtD
Albendazole—Vomiting—Mitoxantrone—breast cancer	7.14e-05	0.000768	CcSEcCtD
Albendazole—Vomiting—Irinotecan—breast cancer	7.14e-05	0.000768	CcSEcCtD
Albendazole—Immune system disorder—Methotrexate—breast cancer	7.11e-05	0.000765	CcSEcCtD
Albendazole—Dizziness—Fluorouracil—breast cancer	7.11e-05	0.000765	CcSEcCtD
Albendazole—Agranulocytosis—Doxorubicin—breast cancer	7.09e-05	0.000763	CcSEcCtD
Albendazole—Rash—Mitoxantrone—breast cancer	7.08e-05	0.000762	CcSEcCtD
Albendazole—Rash—Irinotecan—breast cancer	7.08e-05	0.000762	CcSEcCtD
Albendazole—Dermatitis—Mitoxantrone—breast cancer	7.07e-05	0.000761	CcSEcCtD
Albendazole—Dermatitis—Irinotecan—breast cancer	7.07e-05	0.000761	CcSEcCtD
Albendazole—Headache—Mitoxantrone—breast cancer	7.04e-05	0.000757	CcSEcCtD
Albendazole—Headache—Irinotecan—breast cancer	7.04e-05	0.000757	CcSEcCtD
Albendazole—Erythema multiforme—Epirubicin—breast cancer	6.97e-05	0.00075	CcSEcCtD
Albendazole—Alopecia—Methotrexate—breast cancer	6.96e-05	0.000749	CcSEcCtD
Albendazole—Vomiting—Gemcitabine—breast cancer	6.96e-05	0.000748	CcSEcCtD
Albendazole—Rash—Gemcitabine—breast cancer	6.9e-05	0.000742	CcSEcCtD
Albendazole—Dermatitis—Gemcitabine—breast cancer	6.89e-05	0.000741	CcSEcCtD
Albendazole—Headache—Gemcitabine—breast cancer	6.85e-05	0.000737	CcSEcCtD
Albendazole—Vomiting—Fluorouracil—breast cancer	6.84e-05	0.000736	CcSEcCtD
Albendazole—Hepatitis—Doxorubicin—breast cancer	6.82e-05	0.000734	CcSEcCtD
Albendazole—Rash—Fluorouracil—breast cancer	6.78e-05	0.00073	CcSEcCtD
Albendazole—Dermatitis—Fluorouracil—breast cancer	6.78e-05	0.000729	CcSEcCtD
Albendazole—Hypersensitivity—Paclitaxel—breast cancer	6.75e-05	0.000726	CcSEcCtD
Albendazole—Headache—Fluorouracil—breast cancer	6.74e-05	0.000725	CcSEcCtD
Albendazole—Urinary tract disorder—Doxorubicin—breast cancer	6.74e-05	0.000725	CcSEcCtD
Albendazole—Urethral disorder—Doxorubicin—breast cancer	6.69e-05	0.000719	CcSEcCtD
Albendazole—Nausea—Mitoxantrone—breast cancer	6.67e-05	0.000718	CcSEcCtD
Albendazole—Nausea—Irinotecan—breast cancer	6.67e-05	0.000718	CcSEcCtD
Albendazole—Immune system disorder—Epirubicin—breast cancer	6.66e-05	0.000716	CcSEcCtD
Albendazole—Alopecia—Epirubicin—breast cancer	6.51e-05	0.000701	CcSEcCtD
Albendazole—Nausea—Gemcitabine—breast cancer	6.5e-05	0.000699	CcSEcCtD
Albendazole—Erythema multiforme—Doxorubicin—breast cancer	6.45e-05	0.000694	CcSEcCtD
Albendazole—Nausea—Fluorouracil—breast cancer	6.39e-05	0.000687	CcSEcCtD
Albendazole—Gastrointestinal pain—Docetaxel—breast cancer	6.35e-05	0.000683	CcSEcCtD
Albendazole—Immune system disorder—Doxorubicin—breast cancer	6.16e-05	0.000663	CcSEcCtD
Albendazole—Vertigo—Methotrexate—breast cancer	6.16e-05	0.000663	CcSEcCtD
Albendazole—Gastrointestinal pain—Capecitabine—breast cancer	6.15e-05	0.000661	CcSEcCtD
Albendazole—Abdominal pain—Docetaxel—breast cancer	6.14e-05	0.00066	CcSEcCtD
Albendazole—Body temperature increased—Docetaxel—breast cancer	6.14e-05	0.00066	CcSEcCtD
Albendazole—Leukopenia—Methotrexate—breast cancer	6.14e-05	0.00066	CcSEcCtD
Albendazole—Dizziness—Paclitaxel—breast cancer	6.06e-05	0.000652	CcSEcCtD
Albendazole—Alopecia—Doxorubicin—breast cancer	6.03e-05	0.000648	CcSEcCtD
Albendazole—Urticaria—Capecitabine—breast cancer	5.97e-05	0.000642	CcSEcCtD
Albendazole—Body temperature increased—Capecitabine—breast cancer	5.94e-05	0.000639	CcSEcCtD
Albendazole—Abdominal pain—Capecitabine—breast cancer	5.94e-05	0.000639	CcSEcCtD
Albendazole—Vomiting—Paclitaxel—breast cancer	5.82e-05	0.000627	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.8e-05	0.000624	CcSEcCtD
Albendazole—Rash—Paclitaxel—breast cancer	5.78e-05	0.000621	CcSEcCtD
Albendazole—Dermatitis—Paclitaxel—breast cancer	5.77e-05	0.000621	CcSEcCtD
Albendazole—Vertigo—Epirubicin—breast cancer	5.76e-05	0.00062	CcSEcCtD
Albendazole—Leukopenia—Epirubicin—breast cancer	5.74e-05	0.000618	CcSEcCtD
Albendazole—Headache—Paclitaxel—breast cancer	5.74e-05	0.000617	CcSEcCtD
Albendazole—Hypersensitivity—Docetaxel—breast cancer	5.72e-05	0.000615	CcSEcCtD
Albendazole—Hypersensitivity—Capecitabine—breast cancer	5.54e-05	0.000596	CcSEcCtD
Albendazole—Thrombocytopenia—Methotrexate—breast cancer	5.48e-05	0.000589	CcSEcCtD
Albendazole—Nausea—Paclitaxel—breast cancer	5.44e-05	0.000585	CcSEcCtD
Albendazole—Skin disorder—Methotrexate—breast cancer	5.44e-05	0.000585	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.42e-05	0.000584	CcSEcCtD
Albendazole—Vertigo—Doxorubicin—breast cancer	5.33e-05	0.000574	CcSEcCtD
Albendazole—Leukopenia—Doxorubicin—breast cancer	5.31e-05	0.000572	CcSEcCtD
Albendazole—Dizziness—Docetaxel—breast cancer	5.13e-05	0.000552	CcSEcCtD
Albendazole—Thrombocytopenia—Epirubicin—breast cancer	5.13e-05	0.000552	CcSEcCtD
Albendazole—Skin disorder—Epirubicin—breast cancer	5.09e-05	0.000547	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.02e-05	0.00054	CcSEcCtD
Albendazole—Dizziness—Capecitabine—breast cancer	4.97e-05	0.000535	CcSEcCtD
Albendazole—Vomiting—Docetaxel—breast cancer	4.94e-05	0.000531	CcSEcCtD
Albendazole—Rash—Docetaxel—breast cancer	4.9e-05	0.000527	CcSEcCtD
Albendazole—Dermatitis—Docetaxel—breast cancer	4.89e-05	0.000526	CcSEcCtD
Albendazole—Headache—Docetaxel—breast cancer	4.86e-05	0.000523	CcSEcCtD
Albendazole—Vomiting—Capecitabine—breast cancer	4.78e-05	0.000514	CcSEcCtD
Albendazole—Thrombocytopenia—Doxorubicin—breast cancer	4.74e-05	0.00051	CcSEcCtD
Albendazole—Rash—Capecitabine—breast cancer	4.74e-05	0.00051	CcSEcCtD
Albendazole—Dermatitis—Capecitabine—breast cancer	4.73e-05	0.000509	CcSEcCtD
Albendazole—Headache—Capecitabine—breast cancer	4.71e-05	0.000507	CcSEcCtD
Albendazole—Skin disorder—Doxorubicin—breast cancer	4.71e-05	0.000506	CcSEcCtD
Albendazole—Nausea—Docetaxel—breast cancer	4.61e-05	0.000496	CcSEcCtD
Albendazole—Gastrointestinal pain—Methotrexate—breast cancer	4.58e-05	0.000492	CcSEcCtD
Albendazole—Nausea—Capecitabine—breast cancer	4.46e-05	0.00048	CcSEcCtD
Albendazole—Urticaria—Methotrexate—breast cancer	4.45e-05	0.000478	CcSEcCtD
Albendazole—Abdominal pain—Methotrexate—breast cancer	4.42e-05	0.000476	CcSEcCtD
Albendazole—Body temperature increased—Methotrexate—breast cancer	4.42e-05	0.000476	CcSEcCtD
Albendazole—Gastrointestinal pain—Epirubicin—breast cancer	4.28e-05	0.000461	CcSEcCtD
Albendazole—Urticaria—Epirubicin—breast cancer	4.16e-05	0.000448	CcSEcCtD
Albendazole—Abdominal pain—Epirubicin—breast cancer	4.14e-05	0.000445	CcSEcCtD
Albendazole—Body temperature increased—Epirubicin—breast cancer	4.14e-05	0.000445	CcSEcCtD
Albendazole—Hypersensitivity—Methotrexate—breast cancer	4.12e-05	0.000444	CcSEcCtD
Albendazole—Gastrointestinal pain—Doxorubicin—breast cancer	3.96e-05	0.000426	CcSEcCtD
Albendazole—Hypersensitivity—Epirubicin—breast cancer	3.86e-05	0.000415	CcSEcCtD
Albendazole—Urticaria—Doxorubicin—breast cancer	3.85e-05	0.000414	CcSEcCtD
Albendazole—Abdominal pain—Doxorubicin—breast cancer	3.83e-05	0.000412	CcSEcCtD
Albendazole—Body temperature increased—Doxorubicin—breast cancer	3.83e-05	0.000412	CcSEcCtD
Albendazole—Dizziness—Methotrexate—breast cancer	3.7e-05	0.000398	CcSEcCtD
Albendazole—Hypersensitivity—Doxorubicin—breast cancer	3.57e-05	0.000384	CcSEcCtD
Albendazole—Vomiting—Methotrexate—breast cancer	3.56e-05	0.000383	CcSEcCtD
Albendazole—Rash—Methotrexate—breast cancer	3.53e-05	0.00038	CcSEcCtD
Albendazole—Dermatitis—Methotrexate—breast cancer	3.52e-05	0.000379	CcSEcCtD
Albendazole—Headache—Methotrexate—breast cancer	3.51e-05	0.000377	CcSEcCtD
Albendazole—Dizziness—Epirubicin—breast cancer	3.46e-05	0.000373	CcSEcCtD
Albendazole—Vomiting—Epirubicin—breast cancer	3.33e-05	0.000358	CcSEcCtD
Albendazole—Nausea—Methotrexate—breast cancer	3.32e-05	0.000358	CcSEcCtD
Albendazole—Rash—Epirubicin—breast cancer	3.3e-05	0.000355	CcSEcCtD
Albendazole—Dermatitis—Epirubicin—breast cancer	3.3e-05	0.000355	CcSEcCtD
Albendazole—Headache—Epirubicin—breast cancer	3.28e-05	0.000353	CcSEcCtD
Albendazole—Dizziness—Doxorubicin—breast cancer	3.2e-05	0.000345	CcSEcCtD
Albendazole—Nausea—Epirubicin—breast cancer	3.11e-05	0.000335	CcSEcCtD
Albendazole—Vomiting—Doxorubicin—breast cancer	3.08e-05	0.000331	CcSEcCtD
Albendazole—Rash—Doxorubicin—breast cancer	3.06e-05	0.000329	CcSEcCtD
Albendazole—Dermatitis—Doxorubicin—breast cancer	3.05e-05	0.000328	CcSEcCtD
Albendazole—Headache—Doxorubicin—breast cancer	3.04e-05	0.000327	CcSEcCtD
Albendazole—Nausea—Doxorubicin—breast cancer	2.88e-05	0.00031	CcSEcCtD
Albendazole—CYP1A2—Metabolism—HMMR—breast cancer	4.7e-06	6.58e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	4.61e-06	6.46e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP17A1—breast cancer	4.6e-06	6.44e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS1—breast cancer	4.56e-06	6.37e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ENO1—breast cancer	4.56e-06	6.37e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARGC1B—breast cancer	4.55e-06	6.37e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.54e-06	6.35e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ANGPTL4—breast cancer	4.5e-06	6.3e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ESRRA—breast cancer	4.5e-06	6.3e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.48e-06	6.27e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP2D6—breast cancer	4.47e-06	6.25e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	4.46e-06	6.24e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	4.43e-06	6.2e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	4.43e-06	6.2e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MED12—breast cancer	4.39e-06	6.14e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—DPYD—breast cancer	4.39e-06	6.14e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NCOA2—breast cancer	4.39e-06	6.14e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDOA—breast cancer	4.32e-06	6.05e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA4—breast cancer	4.3e-06	6.02e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CA9—breast cancer	4.3e-06	6.02e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPI—breast cancer	4.27e-06	5.97e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HADHB—breast cancer	4.27e-06	5.97e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—FASN—breast cancer	4.25e-06	5.95e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	4.25e-06	5.94e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—BCHE—breast cancer	4.24e-06	5.93e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	4.2e-06	5.88e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOA3—breast cancer	4.2e-06	5.87e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX2—breast cancer	4.19e-06	5.86e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA2—breast cancer	4.19e-06	5.86e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC5A5—breast cancer	4.18e-06	5.85e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC2A2—breast cancer	4.17e-06	5.83e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX4—breast cancer	4.14e-06	5.79e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SULT1A1—breast cancer	4.14e-06	5.79e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTR—breast cancer	4.08e-06	5.71e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CPT1A—breast cancer	4.08e-06	5.71e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCG2—breast cancer	4.08e-06	5.71e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDH7A1—breast cancer	4.07e-06	5.7e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDH1A1—breast cancer	4.07e-06	5.7e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—IDH1—breast cancer	4.04e-06	5.66e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTA1—breast cancer	4.04e-06	5.66e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NQO1—breast cancer	4.04e-06	5.65e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC2A1—breast cancer	4.04e-06	5.65e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HPGDS—breast cancer	4e-06	5.6e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NAT2—breast cancer	4e-06	5.59e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HBA1—breast cancer	3.98e-06	5.57e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.96e-06	5.54e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP3A4—breast cancer	3.94e-06	5.51e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.92e-06	5.49e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADSL—breast cancer	3.9e-06	5.46e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NME1—breast cancer	3.9e-06	5.46e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—UMPS—breast cancer	3.9e-06	5.46e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—FHL2—breast cancer	3.9e-06	5.46e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PHGDH—breast cancer	3.9e-06	5.46e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTT1—breast cancer	3.88e-06	5.43e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ACHE—breast cancer	3.88e-06	5.43e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP1B1—breast cancer	3.87e-06	5.42e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LDHB—breast cancer	3.83e-06	5.36e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HPSE—breast cancer	3.83e-06	5.36e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—BRIP1—breast cancer	3.83e-06	5.36e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HSP90AA1—breast cancer	3.8e-06	5.32e-05	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.77e-06	5.27e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NCOA1—breast cancer	3.7e-06	5.17e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP17A1—breast cancer	3.68e-06	5.14e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—STK11—breast cancer	3.64e-06	5.1e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP19A1—breast cancer	3.64e-06	5.1e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS1—breast cancer	3.64e-06	5.09e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ENO1—breast cancer	3.64e-06	5.09e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA3—breast cancer	3.63e-06	5.08e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCC1—breast cancer	3.63e-06	5.08e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMMR—breast cancer	3.63e-06	5.08e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	3.61e-06	5.06e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2D6—breast cancer	3.57e-06	4.99e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.51e-06	4.92e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MED12—breast cancer	3.51e-06	4.91e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—DPYD—breast cancer	3.51e-06	4.91e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOA2—breast cancer	3.5e-06	4.9e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDOA—breast cancer	3.45e-06	4.83e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.42e-06	4.78e-05	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.4e-06	4.76e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—FASN—breast cancer	3.4e-06	4.75e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—COMT—breast cancer	3.39e-06	4.74e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—BCHE—breast cancer	3.38e-06	4.73e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTP1—breast cancer	3.37e-06	4.72e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOA3—breast cancer	3.35e-06	4.69e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC5A5—breast cancer	3.34e-06	4.68e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC2A2—breast cancer	3.33e-06	4.65e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMOX1—breast cancer	3.32e-06	4.65e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA9—breast cancer	3.32e-06	4.64e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA4—breast cancer	3.32e-06	4.64e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ITPR1—breast cancer	3.32e-06	4.64e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.29e-06	4.61e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCG2—breast cancer	3.26e-06	4.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CPT1A—breast cancer	3.26e-06	4.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTR—breast cancer	3.26e-06	4.56e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA2—breast cancer	3.23e-06	4.53e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX2—breast cancer	3.23e-06	4.53e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC2A1—breast cancer	3.23e-06	4.52e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NQO1—breast cancer	3.23e-06	4.52e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HPGDS—breast cancer	3.2e-06	4.47e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX4—breast cancer	3.19e-06	4.47e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SULT1A1—breast cancer	3.19e-06	4.47e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCB1—breast cancer	3.19e-06	4.46e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HBA1—breast cancer	3.18e-06	4.44e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP3A4—breast cancer	3.15e-06	4.4e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TYMS—breast cancer	3.13e-06	4.38e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—IDH1—breast cancer	3.12e-06	4.37e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTA1—breast cancer	3.12e-06	4.37e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTT1—breast cancer	3.1e-06	4.34e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ACHE—breast cancer	3.1e-06	4.34e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PLA2G4A—breast cancer	3.1e-06	4.33e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NCOR1—breast cancer	3.1e-06	4.33e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—breast cancer	3.1e-06	4.33e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1B1—breast cancer	3.09e-06	4.33e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NAT2—breast cancer	3.09e-06	4.32e-05	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.08e-06	4.31e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HSP90AA1—breast cancer	3.03e-06	4.25e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPX1—breast cancer	2.97e-06	4.15e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOA1—breast cancer	2.95e-06	4.13e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP17A1—breast cancer	2.93e-06	4.11e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ERCC2—breast cancer	2.91e-06	4.07e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—STK11—breast cancer	2.91e-06	4.07e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP19A1—breast cancer	2.91e-06	4.07e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ENO1—breast cancer	2.9e-06	4.06e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS1—breast cancer	2.9e-06	4.06e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.89e-06	4.05e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.86e-06	4e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2D6—breast cancer	2.85e-06	3.99e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOA2—breast cancer	2.8e-06	3.91e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTHFR—breast cancer	2.74e-06	3.83e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—FASN—breast cancer	2.71e-06	3.79e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—DPYD—breast cancer	2.71e-06	3.79e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MED12—breast cancer	2.71e-06	3.79e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—COMT—breast cancer	2.7e-06	3.78e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—BCHE—breast cancer	2.7e-06	3.78e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTP1—breast cancer	2.69e-06	3.77e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC5A5—breast cancer	2.67e-06	3.73e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDOA—breast cancer	2.66e-06	3.73e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMOX1—breast cancer	2.65e-06	3.71e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ITPR1—breast cancer	2.65e-06	3.71e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOA3—breast cancer	2.59e-06	3.62e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NQO1—breast cancer	2.58e-06	3.6e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC2A1—breast cancer	2.58e-06	3.6e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC2A2—breast cancer	2.57e-06	3.59e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CAV1—breast cancer	2.52e-06	3.53e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.52e-06	3.53e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCG2—breast cancer	2.52e-06	3.52e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTR—breast cancer	2.52e-06	3.52e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CPT1A—breast cancer	2.52e-06	3.52e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP3A4—breast cancer	2.51e-06	3.52e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TYMS—breast cancer	2.5e-06	3.5e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.5e-06	3.5e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLA2G4A—breast cancer	2.47e-06	3.46e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NCOR1—breast cancer	2.47e-06	3.46e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—breast cancer	2.47e-06	3.46e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1B1—breast cancer	2.47e-06	3.46e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HPGDS—breast cancer	2.47e-06	3.45e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HBA1—breast cancer	2.45e-06	3.43e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.42e-06	3.39e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.41e-06	3.37e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTT1—breast cancer	2.39e-06	3.35e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ACHE—breast cancer	2.39e-06	3.35e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPX1—breast cancer	2.37e-06	3.31e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOA1—breast cancer	2.36e-06	3.3e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1A1—breast cancer	2.34e-06	3.28e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ERCC2—breast cancer	2.33e-06	3.25e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—STK11—breast cancer	2.32e-06	3.25e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP19A1—breast cancer	2.32e-06	3.25e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CG—breast cancer	2.3e-06	3.22e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP17A1—breast cancer	2.26e-06	3.17e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ENO1—breast cancer	2.24e-06	3.14e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS1—breast cancer	2.24e-06	3.14e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2D6—breast cancer	2.2e-06	3.08e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTHFR—breast cancer	2.19e-06	3.06e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.18e-06	3.05e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—COMT—breast cancer	2.16e-06	3.02e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOA2—breast cancer	2.16e-06	3.02e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTP1—breast cancer	2.15e-06	3.01e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMOX1—breast cancer	2.12e-06	2.97e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ITPR1—breast cancer	2.11e-06	2.96e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—FASN—breast cancer	2.09e-06	2.93e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—BCHE—breast cancer	2.08e-06	2.92e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC5A5—breast cancer	2.06e-06	2.88e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCB1—breast cancer	2.03e-06	2.85e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CD—breast cancer	2.02e-06	2.83e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CAV1—breast cancer	2.02e-06	2.82e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TYMS—breast cancer	2e-06	2.8e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—breast cancer	2e-06	2.79e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC2A1—breast cancer	1.99e-06	2.78e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NQO1—breast cancer	1.99e-06	2.78e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOR1—breast cancer	1.97e-06	2.76e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.97e-06	2.76e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—breast cancer	1.97e-06	2.76e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NOS3—breast cancer	1.91e-06	2.67e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1B1—breast cancer	1.91e-06	2.67e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX1—breast cancer	1.89e-06	2.65e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1A1—breast cancer	1.87e-06	2.62e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.87e-06	2.62e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ERCC2—breast cancer	1.86e-06	2.6e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CG—breast cancer	1.84e-06	2.57e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOA1—breast cancer	1.82e-06	2.54e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—STK11—breast cancer	1.79e-06	2.51e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP19A1—breast cancer	1.79e-06	2.51e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CB—breast cancer	1.76e-06	2.47e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—breast cancer	1.75e-06	2.44e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTHFR—breast cancer	1.75e-06	2.44e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—COMT—breast cancer	1.67e-06	2.33e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTP1—breast cancer	1.66e-06	2.32e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMOX1—breast cancer	1.64e-06	2.29e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ITPR1—breast cancer	1.63e-06	2.28e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CD—breast cancer	1.61e-06	2.26e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CAV1—breast cancer	1.61e-06	2.25e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—breast cancer	1.59e-06	2.23e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCB1—breast cancer	1.57e-06	2.2e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TYMS—breast cancer	1.54e-06	2.16e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.54e-06	2.15e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NOS3—breast cancer	1.52e-06	2.13e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—breast cancer	1.52e-06	2.13e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOR1—breast cancer	1.52e-06	2.13e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.52e-06	2.13e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTEN—breast cancer	1.52e-06	2.13e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CG—breast cancer	1.47e-06	2.05e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX1—breast cancer	1.46e-06	2.04e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1A1—breast cancer	1.44e-06	2.02e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ERCC2—breast cancer	1.43e-06	2e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CB—breast cancer	1.41e-06	1.97e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—breast cancer	1.39e-06	1.95e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTHFR—breast cancer	1.35e-06	1.88e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CD—breast cancer	1.29e-06	1.8e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—breast cancer	1.27e-06	1.78e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CAV1—breast cancer	1.24e-06	1.74e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NOS3—breast cancer	1.22e-06	1.7e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTEN—breast cancer	1.22e-06	1.7e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CG—breast cancer	1.13e-06	1.58e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CB—breast cancer	1.12e-06	1.57e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—breast cancer	1.11e-06	1.56e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—breast cancer	1.07e-06	1.5e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CD—breast cancer	9.95e-07	1.39e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—breast cancer	9.82e-07	1.37e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTEN—breast cancer	9.71e-07	1.36e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NOS3—breast cancer	9.39e-07	1.31e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—breast cancer	8.77e-07	1.23e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CB—breast cancer	8.67e-07	1.21e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—breast cancer	8.59e-07	1.2e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—breast cancer	8.58e-07	1.2e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTEN—breast cancer	7.49e-07	1.05e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—breast cancer	7.01e-07	9.81e-06	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—breast cancer	6.85e-07	9.58e-06	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—breast cancer	5.59e-07	7.83e-06	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—breast cancer	5.29e-07	7.4e-06	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—breast cancer	4.32e-07	6.04e-06	CbGpPWpGaD
